Global Gene Therapy Partnering Terms and Agreements Market Drivers, Trends and Opportunities 2018
Summary:
A new market study, titled “Global Gene Therapy Partnering Terms and Agreements 2010 to 2018”, has been featured on WiseGuyReports.
Report Description:
The Global Gene Therapy Partnering Agreements 2010-2018 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the world’s leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter gene therapypartnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors gene therapytechnology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Request Sample Report @ http://www.wiseguyreports.com/sample-request/3105266-global-gene-therapy-partnering-terms-and-agreements-2010-to-2018
This report provides details of the latest gene therapy, oligonucletides including aptamers agreements announced in the healthcare sectors.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all gene therapy partnering deals announced since 2010 including financial terms where available including over 500 links to online deal records of actual gene therapy partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
In addition, a comprehensive appendix is provided organized by Gene therapy partnering company A-Z, deal type definitions and Gene therapy partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in Gene therapy partnering and dealmaking since 2010.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Gene therapy technologies and products.
Report scope
Global Gene Therapy Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to gene therapy trends and structure of deals entered into by leading companies worldwide.
Global Gene Therapy Partnering Terms and Agreements includes:
Trends in gene therapy dealmaking in the biopharma industry since 2010
Analysis of gene therapy deal structure
Access to headline, upfront, milestone and royalty data
Case studies of real-life gene therapy deals
Access to over 200 gene therapy deals
The leading gene therapy deals by value since 2010
Most active gene therapy dealmakers since 2010
The leading gene therapy partnering resources
In Global Gene Therapy Partnering Terms and Agreements, the available contracts are listed by:
Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy and technology target
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
View Detailed Report @ https://www.wiseguyreports.com/reports/3105266-global-gene-therapy-partnering-terms-and-agreements-2010-to-2018
Table of Contents
Chapter 1 – Introduction
Chapter 2 – Trends in Gene therapy dealmaking
Chapter 3 – Leading Gene therapy deals
Chapter 4 – Most active Gene therapy dealmakers
Chapter 5 – Gene therapy contracts dealmaking directory
Chapter 6 – Gene therapy dealmaking by technology type
Chapter 7 – Partnering resource center
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Friday September 07 2018, 6:43 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
